LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 4851 - The Continuing Extensions Act of 2010 H.R. 4213 - Americqna Jobs and CLosing Loopholes Act of 2010 P.L. 111-148 - The Patient Protection and Affoirdable Care Act P.L. 111-152 - The Reconcilaition Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | — |
Labor Issues/Antitrust/Workplace LBR
H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drug in to the market, and for other purposes. S. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drug in to the market, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | — |
Copyright/Patent/Trademark CPT
S. 515 A bill to amend title 35, United States Code, to provide Patent Reform S. 610 - A bill to amend title 35, United States Code, to provide for Patent Reform H.R. 1260 - to amend title 35, United States Code, to provide for Patent Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.